Department of Urology, University of Washington, Seattle, Washington.
Division of Urology, Veterans Affairs Puget Sound Health Care System, Seattle, Washington.
J Endourol. 2019 Oct;33(10):850-857. doi: 10.1089/end.2019.0340. Epub 2019 Sep 25.
Ultrasonic propulsion is an investigative modality to noninvasively image and reposition urinary stones. Our goals were to test safety and effectiveness of new acoustic exposure conditions from a new transducer, and to use simultaneous ureteroscopic and ultrasonic observation to quantify stone repositioning. During operation, ultrasonic propulsion was applied transcutaneously, whereas stone targets were visualized ureteroscopically. Exposures were 350 kHz frequency, ≤200 W/cm focal intensity, and ≤3-second bursts per push. Ureteroscope and ultrasound (US) videos were recorded. Video clips with and without stone motion were randomized and scored for motion ≥3 mm by independent reviewers blinded to the exposures. Subjects were followed with telephone calls, imaging, and chart review for adverse events. The investigative treatment was used in 18 subjects and 19 kidneys. A total of 62 stone targets were treated ranging in size from a collection of "dust" to 15 mm. Subjects received an average of 17 ± 14 propulsion bursts (per kidney) for a total average exposure time of 40 ± 40 seconds. Independent reviewers scored at least one stone movement ≥3 mm in 18 of 19 kidneys (95%) from the ureteroscope videos and in 15 of 19 kidneys (79%) from the US videos. This difference was probably because of motion out of the US imaging plane. Treatment repositioned stones in two cases that would have otherwise required basket repositioning. No serious adverse events were observed with the device or procedure. Ultrasonic propulsion was shown to be safe, and it effectively repositioned stones in 95% of kidneys despite positioning and access restrictions caused by working in an operating room on anesthetized subjects.
超声推进是非侵入性成像和重新定位尿路结石的研究方法。我们的目标是测试新换能器的新声暴露条件的安全性和有效性,并使用输尿管镜和超声同时观察来量化结石的重新定位。在手术过程中,经皮应用超声推进,而结石目标则通过输尿管镜可视化。暴露条件为 350kHz 频率、≤200W/cm 焦点强度和≤3 秒/次脉冲。记录输尿管镜和超声(US)视频。将有和没有结石运动的视频片段随机化,并由独立审查员对运动≥3mm 的视频片段进行评分,审查员对暴露情况不知情。通过电话随访、影像学检查和图表审查来评估不良事件。该研究性治疗方法用于 18 名患者的 19 个肾脏。总共治疗了 62 个结石靶,大小从“尘埃”到 15mm 不等。每位患者平均接受 17±14 次推进脉冲(每个肾脏),总暴露时间平均为 40±40 秒。独立审查员在 19 个肾脏中的 18 个(95%)输尿管镜视频中至少有一个结石运动≥3mm,在 19 个肾脏中的 15 个(79%)US 视频中至少有一个结石运动≥3mm。这种差异可能是由于 US 成像平面外的运动。在两个本来需要篮筐重新定位的病例中,治疗重新定位了结石。该设备或手术过程中未观察到严重不良事件。超声推进被证明是安全的,尽管在麻醉患者的手术室中工作受到定位和进入限制,但它仍能有效重新定位 95%的肾脏中的结石。